Cargando…
Polar Profile of Antiviral Peptides from AVPpred Database
Diseases of viral origin in humans are among the most serious threats to health and the global economy. As recent history has shown the virus has a high pandemic potential, among other reasons, due to its ability to spread by air, hence the identification, investigation, containment, and treatment o...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091296/ https://www.ncbi.nlm.nih.gov/pubmed/24993579 http://dx.doi.org/10.1007/s12013-014-0084-4 |
_version_ | 1783510003692339200 |
---|---|
author | Polanco, Carlos Samaniego, José Lino Castañón-González, Jorge Alberto Buhse, Thomas |
author_facet | Polanco, Carlos Samaniego, José Lino Castañón-González, Jorge Alberto Buhse, Thomas |
author_sort | Polanco, Carlos |
collection | PubMed |
description | Diseases of viral origin in humans are among the most serious threats to health and the global economy. As recent history has shown the virus has a high pandemic potential, among other reasons, due to its ability to spread by air, hence the identification, investigation, containment, and treatment of viral diseases should be considered of paramount importance. In this sense, the bioinformatics research has focused on finding fast and efficient algorithms that can identify highly toxic antiviral peptides and to serve as a first filter, so that trials in the laboratory are substantially reduced. The work presented here contributes to this effort through the use of an algorithm already published by this team, called polarity index method, which identifies with high efficiency antiviral peptides from the exhaustive analysis of the polar profile, using the linear sequence of the peptide. The test carried out included all peptides in APD2 Database and 60 antiviral peptides identified by Kumar and co-workers (Nucleic Acids Res 40:W199–204, 2012), to build its AVPpred algorithm. The validity of the method was focused on its discriminating capacity so we included the 15 sub-classifications of both Databases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12013-014-0084-4) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7091296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-70912962020-03-24 Polar Profile of Antiviral Peptides from AVPpred Database Polanco, Carlos Samaniego, José Lino Castañón-González, Jorge Alberto Buhse, Thomas Cell Biochem Biophys Original Paper Diseases of viral origin in humans are among the most serious threats to health and the global economy. As recent history has shown the virus has a high pandemic potential, among other reasons, due to its ability to spread by air, hence the identification, investigation, containment, and treatment of viral diseases should be considered of paramount importance. In this sense, the bioinformatics research has focused on finding fast and efficient algorithms that can identify highly toxic antiviral peptides and to serve as a first filter, so that trials in the laboratory are substantially reduced. The work presented here contributes to this effort through the use of an algorithm already published by this team, called polarity index method, which identifies with high efficiency antiviral peptides from the exhaustive analysis of the polar profile, using the linear sequence of the peptide. The test carried out included all peptides in APD2 Database and 60 antiviral peptides identified by Kumar and co-workers (Nucleic Acids Res 40:W199–204, 2012), to build its AVPpred algorithm. The validity of the method was focused on its discriminating capacity so we included the 15 sub-classifications of both Databases. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12013-014-0084-4) contains supplementary material, which is available to authorized users. Springer US 2014-07-04 2014 /pmc/articles/PMC7091296/ /pubmed/24993579 http://dx.doi.org/10.1007/s12013-014-0084-4 Text en © Springer Science+Business Media New York 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Paper Polanco, Carlos Samaniego, José Lino Castañón-González, Jorge Alberto Buhse, Thomas Polar Profile of Antiviral Peptides from AVPpred Database |
title | Polar Profile of Antiviral Peptides from AVPpred Database |
title_full | Polar Profile of Antiviral Peptides from AVPpred Database |
title_fullStr | Polar Profile of Antiviral Peptides from AVPpred Database |
title_full_unstemmed | Polar Profile of Antiviral Peptides from AVPpred Database |
title_short | Polar Profile of Antiviral Peptides from AVPpred Database |
title_sort | polar profile of antiviral peptides from avppred database |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091296/ https://www.ncbi.nlm.nih.gov/pubmed/24993579 http://dx.doi.org/10.1007/s12013-014-0084-4 |
work_keys_str_mv | AT polancocarlos polarprofileofantiviralpeptidesfromavppreddatabase AT samaniegojoselino polarprofileofantiviralpeptidesfromavppreddatabase AT castanongonzalezjorgealberto polarprofileofantiviralpeptidesfromavppreddatabase AT buhsethomas polarprofileofantiviralpeptidesfromavppreddatabase |